Detalhe da pesquisa
1.
Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis.
Haematologica;
106(1): 74-86, 2021 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31949009
2.
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease.
Leukemia;
37(10): 1994-2005, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37640845
3.
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia.
Nat Commun;
14(1): 1285, 2023 03 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36890137
4.
Myeloid cell diversification and complexity: an old concept with new turns in oncology.
Cancer Metastasis Rev;
30(1): 27-43, 2011 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21267772
5.
CD14 positive cells accelerate hematopoietic stem cell engraftment.
Bone Marrow Transplant;
57(6): 942-948, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35396529
6.
Myeloid cell-based delivery of IFN-γ reprograms the leukemia microenvironment and induces anti-tumoral immune responses.
EMBO Mol Med;
13(10): e13598, 2021 10 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34459560
7.
Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated Macrophages.
Cancer Discov;
10(11): 1758-1773, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32651166
8.
Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy.
Stem Cell Reports;
8(4): 977-990, 2017 04 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28330619
9.
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.
Cancer Cell;
30(3): 377-390, 2016 09 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27622331
10.
Complexity and challenges in defining myeloid-derived suppressor cells.
Cytometry B Clin Cytom;
88(2): 77-91, 2015 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25504825
11.
Complexity and challenges in defining myeloid-derived suppressor cells.
Cytometry B Clin Cytom;
2014 Nov 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25425222
12.
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.
J Exp Med;
211(5): 781-90, 2014 May 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24778419
13.
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.
Cell Rep;
2(3): 628-39, 2012 Sep 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22959433
14.
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.
Cancer Cell;
30(4): 651, 2016 10 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27728809
15.
Therapeutic targeting of myeloid-derived suppressor cells.
Curr Opin Pharmacol;
9(4): 470-81, 2009 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19616475